Work

Phase Ib study of a novel, small-molecule MDM2 inhibitor APG-115 combined with pembrolizumab in U.S. patients with metastatic solid tumors.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3512

Authors: Anthony W. Tolcher, Raghad Karim, Yuefen Tang, Hengbang Wang, Jiao Ji, Jason Chen, Angela Kaiser, Piyush Sheladia, Mohammad Ahmad, ZHIYAN LIANG, Dajun Yang, Yifan Zhai

Institution: Ascentage Pharma Group Inc. (United States)

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030385324

Cites:

Cited by: 1

Related to: 10